Noua Zeelandă - engleză - Medsafe (Medicines Safety Authority)

viatris limited - ciprofloxacin hydrochloride 555mg equivalent to ciprofloxacin 500 mg (anhydrous);   - film coated tablet - 500 mg - active: ciprofloxacin hydrochloride 555mg equivalent to ciprofloxacin 500 mg (anhydrous)   excipient: colloidal silicon dioxide crospovidone hypromellose macrogols magnesium stearate maize starch microcrystalline cellulose opadry white y-22-7719 polydextrose pregelatinised maize starch purified water titanium dioxide triacetin - for complicated urinary tract infections or pyelonephritis due to e.coli in paediatric patients aged 1-17 years. the risk-benefit assessment indicates that administration of ciprofloxacin to paediatric patients is appropriate. treatment should only be initiated after careful benefit/risk evaluation, due to possible adverse events related to joints/surrounding tissues. the use of ciprofloxacin for other indications is not recommended in children.

Noua Zeelandă - engleză - Medsafe (Medicines Safety Authority)

viatris limited - ciprofloxacin hydrochloride 832.5mg equivalent to ciprofloxacin 750 mg (anhydrous);   - film coated tablet - 750 mg - active: ciprofloxacin hydrochloride 832.5mg equivalent to ciprofloxacin 750 mg (anhydrous)   excipient: colloidal silicon dioxide crospovidone hypromellose macrogols magnesium stearate maize starch microcrystalline cellulose opadry white y-22-7719 polydextrose pregelatinised maize starch purified water titanium dioxide triacetin - for complicated urinary tract infections or pyelonephritis due to e.coli in paediatric patients aged 1-17 years. the risk-benefit assessment indicates that administration of ciprofloxacin to paediatric patients is appropriate. treatment should only be initiated after careful benefit/risk evaluation, due to possible adverse events related to joints/surrounding tissues. the use of ciprofloxacin for other indications is not recommended in children.

Noua Zeelandă - engleză - Medsafe (Medicines Safety Authority)

mundipharma new zealand ltd - oxycodone hydrochloride 10mg;  ;   - modified release tablet - 10 mg - active: oxycodone hydrochloride 10mg     excipient: ammonio methacrylate copolymer lactose monohydrate magnesium stearate opadry white y-5-18024-a povidone purified talc stearyl alcohol triacetin - the management of moderate to severe chronic pain unresponsive to non-narcotic analgesia

Noua Zeelandă - engleză - Medsafe (Medicines Safety Authority)

mundipharma new zealand ltd - oxycodone hydrochloride 120mg - modified release tablet - 120 mg - active: oxycodone hydrochloride 120mg excipient: ammonio methacrylate copolymer lactose monohydrate magnesium stearate opadry purple 15b20201 povidone purified talc purified water stearyl alcohol triacetin - the management of moderate to severe chronic pain unresponsive to non-narcotic analgesia.

Noua Zeelandă - engleză - Medsafe (Medicines Safety Authority)

mundipharma new zealand ltd - oxycodone hydrochloride 15mg equivalent to 13.5 mg oxycodone base - modified release tablet - 15 mg - active: oxycodone hydrochloride 15mg equivalent to 13.5 mg oxycodone base excipient: lactose monohydrate magnesium stearate methacrylic acid copolymer opadry grey 05b97512 povidone purified talc stearyl alcohol triacetin - the management of moderate to severe chronic pain unresponsive to non-narcotic analgesia

Noua Zeelandă - engleză - Medsafe (Medicines Safety Authority)

mundipharma new zealand ltd - oxycodone hydrochloride 20mg;  ;   - modified release tablet - 20 mg - active: oxycodone hydrochloride 20mg     excipient: ammonio methacrylate copolymer lactose monohydrate magnesium stearate opadry pink ys-1-14518-a povidone purified talc stearyl alcohol triacetin - the management of moderate to severe chronic pain unresponsive to non-narcotic analgesia

Noua Zeelandă - engleză - Medsafe (Medicines Safety Authority)

mundipharma new zealand ltd - oxycodone hydrochloride 30mg equivalent to 27 mg oxycodone base - modified release tablet - 30 mg - active: oxycodone hydrochloride 30mg equivalent to 27 mg oxycodone base excipient: lactose monohydrate magnesium stearate methacrylic acid copolymer opadry brown ys-1-16518-a povidone purified talc stearyl alcohol triacetin - the management of moderate to severe chronic pain unresponsive to non-narcotic analgesia

Noua Zeelandă - engleză - Medsafe (Medicines Safety Authority)

mundipharma new zealand ltd - oxycodone hydrochloride 40mg;  ;   - modified release tablet - 40 mg - active: oxycodone hydrochloride 40mg     excipient: ammonio methacrylate copolymer lactose monohydrate magnesium stearate opadry yellow ys-1-12525-a povidone purified talc stearyl alcohol triacetin - the management of moderate to severe chronic pain unresponsive to non-narcotic analgesia

Noua Zeelandă - engleză - Medsafe (Medicines Safety Authority)

mundipharma new zealand ltd - oxycodone hydrochloride 5mg equivalent to 4.5 mg of oxycodone base;   - modified release tablet - 5 mg - active: oxycodone hydrochloride 5mg equivalent to 4.5 mg of oxycodone base   excipient: ammonio methacrylate copolymer brilliant blue fcf hypromellose lactose monohydrate macrogol 400 magnesium stearate opadry blue 06b20843 povidone purified talc stearyl alcohol titanium dioxide triacetin - the management of moderate to severe chronic pain unresponsive to non-narcotic analgesia.

Noua Zeelandă - engleză - Medsafe (Medicines Safety Authority)

mundipharma new zealand ltd - oxycodone hydrochloride 60mg - modified release tablet - 60 mg - active: oxycodone hydrochloride 60mg excipient: ammonio methacrylate copolymer lactose monohydrate magnesium stearate opadry red 15b25501 povidone purified talc purified water stearyl alcohol triacetin - the management of moderate to severe chronic pain unresponsive to non-narcotic analgesia.